Cryoport, Inc. (NASDAQ:CYRX) Director Sells $54,972.74 in Stock

Cryoport, Inc. (NASDAQ:CYRX) Director Ramkumar Mandalam sold 7,369 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $7.46, for a total transaction of $54,972.74. Following the completion of the transaction, the director now owns 59,497 shares in the company, valued at $443,847.62. This trade represents a 11.02 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Cryoport Trading Up 0.8 %

CYRX opened at $7.33 on Friday. Cryoport, Inc. has a twelve month low of $5.32 and a twelve month high of $20.10. The company has a 50-day simple moving average of $7.31 and a 200 day simple moving average of $8.23. The company has a quick ratio of 5.32, a current ratio of 5.70 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $362.32 million, a price-to-earnings ratio of -2.17 and a beta of 1.62.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on CYRX shares. UBS Group upped their price target on shares of Cryoport from $7.00 to $9.00 and gave the company a “neutral” rating in a research note on Friday, October 18th. Roth Mkm decreased their price target on shares of Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, Cryoport presently has an average rating of “Moderate Buy” and an average price target of $12.50.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Comerica Bank lifted its holdings in shares of Cryoport by 73.0% in the first quarter. Comerica Bank now owns 3,481 shares of the company’s stock worth $62,000 after acquiring an additional 1,469 shares during the last quarter. Quest Partners LLC lifted its holdings in shares of Cryoport by 1,083,000.0% in the second quarter. Quest Partners LLC now owns 10,831 shares of the company’s stock worth $75,000 after acquiring an additional 10,830 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Cryoport in the 3rd quarter valued at approximately $82,000. Hsbc Holdings PLC bought a new position in Cryoport in the 2nd quarter valued at approximately $92,000. Finally, Intech Investment Management LLC bought a new position in Cryoport in the 3rd quarter valued at approximately $105,000. Institutional investors own 92.90% of the company’s stock.

Cryoport Company Profile

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.